Updated: 8 Wall Street analysts have issued ratings and price targets for Humanigen in the last 12 months. Their average twelve-month price target is $29.88, predicting that the stock has a possible upside of 73.49%. The high price target for HGEN is $37.00 and the low price target for HGEN is $21.00. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus rating of "Buy. https://www.marketbeat.com/stocks/NASDAQ/HGEN/price-target/